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ABSTRACT
We present a 31 years old lady who was 19 days postpartum who was admitted with fits and loss of consciousness. 
At presentation Glasgow Coma Scale was 8/15. No focal deficit. CT scan brain showed findings suggestive of 
subarachnoid haemorrhage(SAH) in left sylvian fissure along with few parenchymal haemorrhagic areas in frontal and 
parietal lobes. MRI brain and MRV confirmed superior sagittal sinus thrombosis, inferior sagittal, straight and right 
transverse and sigmoid sinus thrombosis. Patient was treated conservatively and was anticoagulated for 6 months and 
had a complete recovery. Further workup of thrombophilia was negative. Postpartum being the only risk factor for 
cerebral venous thrombosis (CVT) in her. SAH can be a rare presenting symptom of CVT and should not preclude 
patients from receiving anticoagulation.
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C A S E  R E P O R T
INTRODUCTION:
CVT is responsible for 1% to 2% of all strokes in 
adults.1 CVT presenting with an associated 
subarachnoid hemorrhage (SAH) has been rarely 
reported in literature.2,3
We present a similar case of postpartum CVT who 
presented with a sylvian SAH and was treated with 
anticoagulation and fully recovered.
Case report
A 31year old female resident of Islamabad presented 
with one-day history of headache, fits associated with 
loss of consciousness. She had a history of child birth 
about 19 days ago, which was normal delivery without 
any complications.  On examination at presentation she 
had stable vital signs. Her Glasgow Coma Scale was 
however 8/15. Pupils were equal and reactive. There 
were no signs of meningeal irritation. There was no 
focal deficit. Her CT scan showed left sylvian fissure 
subarachnoid haemorrhage as well as findings 
suggestive of superior sagittal sinus and right 
transverse sinus thrombosis as shown in figure 1 and 2. 
Next important question was whether to start her on 
anticoagulation or not in presence of subarachnoid 
haemorrhage. She was started on LMWH in therapeutic 
dose and bleeding was monitored. 
Figure 1. CT brain(plain) of the patient showing 
hyperdense signal in left sylvian fissure suggestive of 
subarachnoid haemorrhage.
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Figure2. CT brain (plain) sagittal view showing 
hyperdense superior sagittal sinus suggestive of 
superior sagittal thrombosis.
Her MRI and MRV brain confirmed superior sagittal 
sinus thrombosis, inferior sagittal, 
straight and right transverse and sigmoid sinus 
thrombosis. Her thrombophilia workup was also done 
and was found negative. Fortunately, she improved 
really quickly and had no worsening of haemorrhage. 
Her CT angiography brain was also done and ruled out 
any intracranial aneurysms. She was given 
anticoagulation for 6 months and had full resolution of 
symptoms.
Discussion
SAH can be a rare presentation of CVT. The distribution 
of SAH associated with CVT is usually different from 
that of SAH of arterial origin, which has a characteristic 
pattern. In fact, when SAH is localized at the cerebral 
convexity and spares the basal cisterns and skull base, 
CVT should be considered.4
The exact mechanism of cortical SAH caused by CVT is 
unknown. One possibility is the rupture of venous 
parenchymal hemorrhagic infarcts into the 
subarachnoid space.5,6 Another possible mechanism 
is venous hypertension and subsequent rupture of 
dilated, valueless, thin-walled, bridging subarachnoid 
cortical veins devoid of smooth muscle fibers.5
A third mechanism of SAH development could be a 
local inflammatory response caused by CVT, which 
would increase the vascular permeability allowing for 
extravasation of blood into the subarachnoid space6.
Management of SAH secondary to CVT is quite different 
from that of arterial SAH. The usual treatment of sinus 
thrombosis is anticoagulation. Systemic 
anticoagulation is the first line treatment for CVT 
because of its efficacy, safety, and feasibility.7 In a 
further placebo-controlled trial, 60 patients were 
randomized to either lower molecular weight heparin 
followed by warfarin or placebo.8 The anticoagulated 
patients had better outcomes than controls, but the 
difference was not statistically significant. The 
investigators suggested that anticoagulation with 
LMWH was safe, even in patients with cerebral 
hemorrhage.8
CVT should be considered in the differential diagnosis 
of patients presenting with SAH without evidence of 
aneurysm and presence of SAH should not preclude 
patients from receiving anticoagulation.
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